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Summary
Background: The human virome consists of animal-cell viruses causing transient
infections, bacteriophage (phage) predators of bacteria and archaea, endogenous
retroviruses and viruses causing persistent and latent infections. High-throughput,
inexpensive, sensitive sequencing methods and metagenomics now make it possible
to study the contribution dsDNA, ssDNA and RNA virus-like particles make to the
human virome, and in particular the intestinal virome.
Aim: To review and evaluate the pioneering studies that have attempted to charac-
terise the human virome and generated an increased interest in understanding how
the intestinal virome might contribute to maintaining health, and the pathogenesis
of chronic diseases.
Methods: Relevant virome-related articles were selected for review following
extensive language- and date-unrestricted, electronic searches of the literature.
Results: The human intestinal virome is personalised and stable, and dominated by
phages. It develops soon after birth in parallel with prokaryotic communities of the
microbiota, becoming established during the first few years of life. By infecting
specific populations of bacteria, phages can alter microbiota structure by killing host
cells or altering their phenotype, enabling phages to contribute to maintaining
intestinal homeostasis or microbial imbalance (dysbiosis), and the development of
chronic infectious and autoimmune diseases including HIV infection and Crohn’s dis-
ease, respectively.
Conclusions: Our understanding of the intestinal virome is fragmented and requires
standardised methods for virus isolation and sequencing to provide a more complete
picture of the virome, which is key to explaining the basis of virome-disease associ-
ations, and how enteric viruses can contribute to disease aetiologies and be rationa-
lised as targets for interventions.
The Handling Editor for this article was Professor Jonathan Rhodes, and this commissioned
review was accepted for publication after full peer-review.
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1 | THE HUMAN VIROME
Viruses are thought to be the most abundant and diverse entities
on Earth, numbering as many as 1031 virus-like particles (VLPs),1
though this paradigm is likely to change in light of information from
large-scale sequencing surveys of marine environments and
improved analytical tools.2 With the advent of new, sequence-based
technologies that do not rely on the ability to isolate viruses for
their identification, it is now possible to define and characterise
viruses in different environmental samples in greater detail than ever
before, which has resulted in an increased interest in the role the
viral assemblage of the human gut microbiota plays in health and
disease. The following reviews our current knowledge on the human
intestinal virome.
A virome comprises all the nucleic acids (ssDNA, dsDNA, ssRNA
and dsRNA) belonging to the VLPs associated with a particular
ecosystem. The human virome is a genetically complex component
of the microbiome, with the blood, nose, skin, conjunctiva, mouth,
vagina, lungs and gastrointestinal (GI) tract harbouring their own dis-
tinct virus assemblages (Table S1). The genetic content of VLPs com-
prising bacteriophages (phages) that infect bacteria and archaea
and, to a much lesser extent, human-, plant-, amoebae- and ani-
mal-infecting viruses found along the GI tract constitute the human
intestinal virome (Figure 1).
2 | BACTERIOPHAGES
Phages can be lytic or lysogenic. Lytic (virulent) phages bind to
specific host-cell receptors, then penetrate and infect their host cell
to hijack its replication and translation machinery to produce viri-
ons; once sufficient virions have accumulated (tens to thousands,
depending on the phage), the lytic enzymes they produce cause
the host cell to lyse, releasing the virions into the surrounding
environment where they can infect new host cells. Lytic phages
can have narrow or broad host ranges, infecting only one strain of
a prokaryote or multiple species of closely related prokaryotes.
These entities have been used in the past to treat infections, and
have recently been revisited as alternatives to antibiotic therapies
for a range of infections and as means of controlling food-contami-
nating bacteria such as Listeria spp.3 Their gene products are also
of interest in biotechnological and medical applications.4 Lysogenic
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F IGURE 1 The mammalian intestinal virome comprises viruses that infect eukaryotic and prokaryotic cells. It is established soon after birth
and is dominated by viruses that infect bacteria (ie, phages). The virome establishes a mutualistic relationship with eukaryotes/prokaryotes,
contributing to intestinal homeostasis by influencing microbial ecology and host immunity. Composition of the virome is influenced by
numerous factors that affect viruses directly (infection) or change host-cell populations (eg, antibiotics, diet). Members of the virome may
contribute to the pathogenesis of certain diseases via microbial host lysis leading to dysbiosis, infection of epithelial cells, and/or translocation
of the compromised or damaged mucosal barrier to gain access to underlying tissues and immune cells, leading to immune activation. Dysbiosis
can be defined as a microbial imbalance or any changes to the composition of resident microbial communities relative to the community found
in healthy individuals.101-103 Virome association with certain disease states is characterised by changes in diversity, and predominance of
specific virotypes (eg, members of the order Caudovirales in IBD)
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(temperate) phages do not kill their host but instead integrate into
their host’s genome without interfering with its replication, incorpo-
rating the phage into its genome as a prophage that is transmitted
to its progeny at each cell division. Lysogenic phages can be
converted to a lytic cycle in response to environmental stressors
(eg, antibiotics).
Phage-host interactions influence host and viral evolution. The
ability of phages to transfer genes from one prokaryotic host to
another can lead to increased diversification of viral species, and
increased antibiotic resistance and/or induction of toxins or viru-
lence factors in prokaryotes.5 Some phages alter the antigenicity of
their hosts by producing enzymes that modify the O-antigen compo-
nent of lipopolysaccharides.6 Modification of surface structures of
prokaryotes has the potential to affect microbial interactions with
the human host, and influence niche specialisation within the GI
tract.7 Presence of clustered regularly interspaced short palindromic
repeats (CRISPRs) confers upon prokaryotes resistance to phage
infection and contributes to prokaryotic adaptive immunity. Analyses
of metagenomic sequence data provide detailed information on
phage-host and phage-phage competition within the human faecal
microbiome, implying CRISPR spacers are actively and continuously
acquired by prokaryotes in response to the presence of phages
in the GI tract.8 The potential effects of such phage-host inter-
actions on microbiota composition/function or host health are
unknown.
3 | CHARACTERISING THE HUMAN
INTESTINAL VIROME
Viruses do not encode universally conserved genes such as the 16S
or 18S rRNA genes of prokaryotes and eukaryotes, respectively, and
are genetically highly diverse. Consequently, it is not possible to use
metataxonomic approaches such as 16S rRNA gene sequencing to
characterise VLPs within ecosystems. Traditionally, classical
approaches—mainly microscopy and cultivation—have been relied
upon to characterise VLPs in the human gut.
Based on transmission electron microscopy (TEM), mucosal sam-
ples contain ~1.2 9 109 VLPs/biopsy.9 VLPs have been detected in
caecal contents at 106/mL using TEM10 with faeces harbouring 108-
109 VLPs/g wet weight.10,11 In all GI contents examined to date by
microscopy, the overwhelming majority of VLPs have been phages
of the order Caudovirales, with the human GI tract estimated to har-
bour 1015 phages in total.3,9,10,12 The order Caudovirales encom-
passes most known phages (Figure 2), comprising the families
Myoviridae (nonenveloped, head-tail structure, contractile, dsDNA
genomes of 30-250 kb), Siphoviridae (nonenveloped, head-tail struc-
ture, noncontractile, dsDNA genomes of ~50 kb) and Podoviridae
(nonenveloped, head-short tail structure, dsDNA genomes of 40-
42 kb). Every individual harbours a morphologically unique phage
population.10,12
For many years, the isolation of gut-associated phages was con-
fined to samples derived from sewage or water sources, with the
presence of phages considered indicative of nonspecific (animal,
human) faecal contamination. Recently attention has turned to isolat-
ing phages directly from human microbiota samples (Table 1). While
in its infancy, this work holds great promise for improving our
knowledge of the gut virome, will facilitate metagenomic studies and
aid in vitro and in vivo studies investigating the influence of phages
on prokaryote populations in the human gut. Significant improve-
ments to isolation methods are needed to allow the efficient and
reliable isolation and characterisation of phages infecting fastidious
anaerobic prokaryotes. In addition, no single isolation approach is
applicable to all prokaryotes, and based on evidence from Bac-
teroides spp. it is likely gut-associated phages have very narrow host
ranges.7
Study of viruses in clinical settings will be facilitated by methods
such as the Virome Capture Sequencing platform for Vertebrate
viruses (VirCapSeq-VERT), a system that uses ~2 million probes tar-
geting the genomes of 207 viruses known to infect humans and
other vertebrates to capture viral nucleic acids present in blood and
tissue homogenates.13
4 | METAGENOMICS AND THE HUMAN
INTESTINAL VIROME
The only reliable molecular method currently available for routine
surveys of the human virome is metagenomics. Metagenomics is a
culture-independent, molecular-based approach that allows func-
tional and sequence-based analyses of the collective microbial gen-
omes contained in an environmental sample, providing a powerful
approach for exploring the ecology of complex microbial communi-
ties.14 It has been used to examine prokaryotic communities associ-
ated with the human gut microbiome in health and disease,15-18 and
to examine viromes associated with different regions of the human
body (Table S1).
A protocol involving homogenisation of faeces in buffer, centrifu-
gation (to remove cell debris), tangential flow filtration (TFF) (to con-
centrate large-volume samples and isolate VLPs), ultracentrifugation
and metagenomic reconstruction was used to characterise the first
human faecal virome.19 However, recent improvements in recovery
methods give the potential to characterise human-associated VLP
assemblages at the molecular level in greater detail than ever before
(Table 2). These methods have yet to be compared with one another
directly, and the issue of which DNA extraction method or kit is best
for use with gut virome samples has not been addressed. To avoid
the problems that have beset studies of the prokaryotic component
of the gut microbiome with respect to reproducibility, contaminants
and comparable approaches across studies and datasets, it is impor-
tant the virome community adopts robust, standardised methods at
the earliest opportunity.
The first faecal metagenome was generated from the faeces of a
33-year-old healthy male using a clone-based strategy.19 It was pre-
dicted to comprise ~1,200 virotypes, with the most abundant virus
making up 4% of the total. Siphophage sequences made up the
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majority of recognisable viruses, with 59% of the sequences not
related to anything within public databases. Sequences with signifi-
cant matches to myophages, podophages and microphages were also
detected. The most common sequence matches were with phages
associated with Listeria monocytogenes, Burkholderia thailandensis and
Lactococcus lactis. Prophages within bacterial genomes also made a
large contribution to the recognisable viruses identified.19 Numerous
sequences with similarity to phages that infect Gram-positive bacte-
ria were also detected, reflecting results from studies on faecal bac-
terial populations that have shown Firmicutes and, to a lesser extent,
Actinobacteria are among the most predominant bacteria in human
faeces. This suggested the most abundant phage groups in a given
environment reflect the kinds of microbes found in that
environment.1
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F IGURE 2 Breakdown of complete genomes of members of the order Caudovirales (dsDNA viruses, no RNA stage) available from NCBI
Genome on November 21, 2016 (n = 1943). The number of publicly available Caudovirales genomes had only increased to 2044 by July 6,
2017. Genera of prokaryotes (with some families and higher taxa) infected by phages are shown around the chart; colours correspond to phyla
(kingdom in the case of the Archaea) of prokaryotes infected by different phages. Aggregated data are shown for each of the three families of
the order Caudovirales in the large plot. Myoviridae, n = 538 complete genomes; Siphoviridae, n = 1063 complete genomes; Podoviridae,
n = 342 complete genomes. Larger versions of the pie charts shown in this figure are available in Supporting Information
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5 | MINING TOTAL COMMUNITY
METAGENOMES TO REVEAL VIRUS
DIVERSITY
With the exceptions of the Proteobacteria, mycobacteria and some
lactic acid bacteria, very few phages infecting prokaryotes have been
isolated and sequenced (Figure 2). Between 4% and 22% of DNA in
total community metagenomes can be derived from VLPs.20-22 This
allows potential recovery of phage sequences not well represented
in virome studies, though still excludes RNA viruses from detailed
analyses.
Human gut-specific Bacteroides phage φB124-14 was isolated
from municipal waters and infects Bacteroides fragilis GB-124 and a
limited range of other B. fragilis strains.7,23 Sequences with homology
to this phage were found in faecal metagenomes from MetaHIT
(104/124) and Japan (3/13), and human gut viromes (2/16).
Sequences associated with this phage were not found in American
gut-associated datasets (metagenome or virome), suggesting geo-
graphical variation in distribution of gut-associated phages.7 Using a
similar metagenomic mining approach but with major capsid protein
VP1 specific for the ssDNA phage family Microviridae, members of
the subfamilies Gokushovirinae, Alpnavirinae and Pichovirinae were
detected in faecal metagenomes.24
By using phage genome signature-based recovery with meta-
genomes, several (predominantly temperate) potential gut-specific
phages infecting members of the order Bacteroidales were identi-
fied.21 This alignment-free approach was able to resolve phage
sequences not readily detected by conventional alignment-driven
approaches. The main limitation of this method is the lack of
available genome sequences from isolated phages, as “driver
sequences” are required to provide baseline information upon
which inferences can be made regarding sequence data and host
phylogeny (only four such “driver sequences” were required in the
Bacteroidales study).21 Using co-occurrence profiling, crAssphage
was identified in publicly available metagenomes, and by CRISPR
analysis and co-occurrence profiling predicted to infect Bacteroides
or Prevotella spp.22 This phage, with a 97,065 bp genome encod-
ing 80 proteins, is predicted to make up to 24%-90% of all reads
in faecal viromes, and 1.7% of reads in all human faecal metagen-
omes (up to 22% in the HMP dataset). Long-range PCR and San-
ger sequencing were used to confirm the presence of the genome
in a faecal sample. The role of this phage in the human gut is
unknown, and a representative of it remains to be isolated and
purified.
Novel human-associated viruses present in the gut virome can
also be detected using viral metagenomics. Analyses of diarrhoea
samples from Dutch patients with unexplained acute gastroenteritis
led to the identification of novel members of the families Anelloviri-
dae, Picobirnaviridae, Herpesviridae and Picornaviridae.25 The role of
these viruses in gastroenteritis is still to be established. It is also
important to remember in exploratory (and other) studies that
detecting virus nucleic acids in samples gives no indication of
whether the viruses infect human or other cells.26
6 | INDIVIDUAL INTESTINAL VIROMES
ARE UNIQUE, BUT SOME PHAGES ARE
SHARED AMONG INDIVIDUALS
A longitudinal study (three time points over 1 year) of four pairs of
adult monozygotic twins and their mothers demonstrated that, while
the faecal prokaryote communities of related individuals are very
similar, each individual harbours a unique faecal virome.27 Intraper-
sonal diversity of the virome was low, with >95% of viruses retained
over a 1-year period, with a few temperate phages dominating the
viromes. This contrasts with Lotka-Volterra predator-prey relation-
ships, in which cyclic changes in phage and prokaryote abundance
would be expected, or with kill-the-winner dynamics, in which
detectable changes in phage-host pairs would be detected. The
majority (81%) of sequenced reads did not match any known viruses,
and only 3.2  2.8% reads could be assigned functions using KEGG.
The predicted hosts of the identifiable phages were members of the
phyla Bacteroidetes and Firmicutes, in accordance with the predomi-
nant bacteria detected in the samples by 16S rRNA gene sequenc-
ing. The ratio of virotypes to bacterial phylotypes was predicted to
be ~1:1.
Assembly of sequence data from four deep-sequenced DNA vir-
omes (8.1 Gb sequence data in total) from two healthy individuals
led to recovery of 4301 contigs, representing 72 complete phage
genomes plus potentially complete and partial phage genomes.28 A
minority (1703) of the contigs and 63/72 complete genomes con-
tained at least one ORF with homology to a phage protein. Only
314 of all contigs contained homologues that allowed their assign-
ment to a higher phage taxon, with order Caudovirales
TABLE 1 Phages recently isolated from the human gut microbiota
Host bacterium Source of host bacterium Phage(s); source Lytic/lysogenic
Klebsiella pneumoniae L4-FAA582 Caecal effluent KLPN1a; caecal effluent Lytic
Clostridium difficile HMC11483 Faeces Phage tail-like particle; Clostridium difficile HMC114 Lysogenic
Escherichia coli DPC605184 Unknown ɸAPCEc01, ɸAPCEc02, ɸAPCEc03; faeces Lytic
Proteus mirabilis CEMTC 7385 Faeces of a patient after
bariatric surgery
PM16a; faeces Lytic
aPhage isolated from same sample as host strain.
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predominating. Using a low-stringency approach (ie, recruitment of a
single sequence read to any of the 4301 contigs) to detect genomes
in samples, 17% of the contigs were found to be present in both
individuals in at least one sample and 7% were present in all four
samples. Sequence reads from ~20% of 62 faecal viromes (generated
from healthy cohorts in three American cities and Cambridge, UK29)
mapped to 160 contigs. A consortium of 155 phages contributed to
the “healthy gut phageome” (HGP), though only 23 phages were pre-
sent in >50% of samples (“core” phages, including crAssphage and
nine other complete genomes), and 132 were present in 20%-50%
of samples (“common” phages); 1679 were present in 2%-19% (“low
overlap” phages). The HGP represented only 4% of the total phage
community, with the expectation that the HGP will increase in size
by analysing additional healthy individuals using deep sequencing.28
Although it has been proposed the HGP may play a role in maintain-
ing and possibly restoring a dysbiotic microbiota,30 how this might
be achieved, and the role and mechanisms by which shared commu-
nities of phages contribute to gut health, remains a matter of
debate.
7 | INTESTINAL VIROME VARIATION AND
STABILITY
Interindividual variation among and intra-personal stability of faecal vir-
omes was confirmed in six healthy individuals enrolled in a dietary inter-
vention study (two high-fat/low-fibre diet; three low-fat/high-fibre diet,
one ad-lib diet).20 Greater sequencing depth was achieved compared
TABLE 2 Methods used for recovering VLPs from intestinal/faecal contents
Sample(s) Comments
Caecal and faecal10 Filtration and polyethylene glycol (PEG) precipitation to concentrate VLPs, with and without CsCl centrifugation
0.45 lm filters instead of 0.22 lm doubled the number of VLPs and the quantity of DNA recovered from samples
Used pulsed-field gel electrophoresis to demonstrate differences in viromes among individuals
Faecal86 ViSeq (VIDISCA enrichment of VLPs/conversion of RNA to cDNA/SLIM)
Documented HIV-1 and overall viral content of faecal samples of late-stage AIDS patients
Faecal12 Microfiltration-free PEG and TFF methods optimised
Spiked samples with low numbers of c2 (Siphoviridae), /29 (Podoviridae), and T4 (Myoviridae) phages to determine phage
recovery
PEG more effective than TFF, yielding 16 times more phage particles and 68 times more phage DNA per volume
Increased recovery of Caudovirales at the expense of eukaryotic viruses
Mock virome containing
9 phages/viruses66
NetoVIR (novel enrichment technique of viromes)
Homogenisation with glass beads led to destruction of viruses
Increasing centrifugation times at 17,000 g led to reductions in virus recovery, possibly due to presence of aggregates in
the sample
Filtering through 0.2, 0.45 or 0.8 lm filters led to significant losses of mimivirus; 0.2 lm filter led to significant loss of
Herpesvirus
Chloroform treatment led to losses of enveloped viruses (coronavirus and mimivirus) and nonenveloped viruses
(rotavirus and polyomavirus)
Demonstrated effect of increasing number of PCR cycles on recovery of viruses in the mock community (ie, lower yields
of some viruses as number of cycles increased)
No data presented on NetoVir when used on gut/faecal samples
Faecal87 Filtered (0.2 lm) sample subjected to fluorescence-activated cell sorting (FACS)
Only looked at a small fraction of the faecal virome, but different viral fractions could theoretically be separated using
FACS
Allowed direct sequencing of viral DNA without the need for whole-genome amplification
Avoided contamination with bacteria
Led to improved assembly of viral genomes
Artificial community
of 25 viruses88
Mock community contained dsDNA (Adenoviridae, Herpesviridae), dsRNA (Reoviridae), and ssRNA (Astroviridae, Caliciviridae,
Coronaviridae, Picornaviridae, Orthomyxoviridae, Paramyxoviridae) viruses
Filtration and nuclease digestion had little effects on overall results
Pre-amplification of nucleic acids prior to sequencing led to more biased genome coverage with near-duplicate reads
accumulating over the same region, decreasing genome coverage
ScriptSeq > TruSeq > Nextera for virus detection and genome coverage
Maximum of 22/25 viruses recovered in sequenced viromes
Artificial intestinal
microbiota (six phages,
two bacteria67
CsCl centrifugation most efficient for removing host DNA, but discriminated against some phages and was not
reproducible; not suitable for quantitative studies
Did not process PEG-precipitated samples for sequencing
Recommended using filtration + DNase, or dithiothreitol treatment + filtration + DNase to collect VLPs, but did not test
on human faeces
Cautioned about over-interpreting data: abundances of individual phages within samples deviated by more than one
order of magnitude from the actual input number of phage particles
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with earlier studies (336 Mb vs 70 Mb across all samples,19,27 with
98% of sequence reads having no known hits in databases. Greater
sequencing depth allowed assembly of contigs (7175 of at least 500 bp
in length), with 87% of reads contributing to these. PHACCS (PHAge
Communities from Contig Spectrum)-predicted median species richness
of the samples was 44 (range 19-785), in agreement with Reyes et al27
(median of 35, range 10-984). Tailed phages predominated (Siphoviridae,
18% of the total;Myoviridae, 10%; Podoviridae, 4.8%;Microviridae, 0.9%;
other families, 0.4%). The majority of contigs (55%) shared no significant
amino acid homology with any phage family, while 11% had homology
to multiple phage families. No eukaryotic viruses were detected. Minor
convergence of viromes was seen when individuals were fed the same
diet, though each individual retained a unique virome. Induction of lyso-
geny may have contributed to changes in phage abundance during the
dietary intervention, though this has not been demonstrated empiri-
cally. In contrast to total faecal metagenomes, which were enriched in
genes for synthesis (amino acid, carbohydrate precursors), translational
machinery and cell component biogenesis, VLPs were enriched for
genes associated with replication, recombination, repair and unknown
functions; consistent with viruses recruiting host-cell machinery for
their propagation. Findings regarding prophages were not in accord
with previous studies (they did far more in-depth analyses than previous
studies): 2814 contigs had significant amino acid homology with an
ACLAME prophage sequence, 41% were assigned to Firmicutes, 0.9%
were assigned to Bacteroidetes, 16% were assigned to the Proteobacte-
ria.20 This pattern did not match abundance of bacteria within samples,
leading to the suggestion prevalence of temperate phages in faeces
may differ among different phyla with the caveat that conclusions were
dependent on phage sequences available in public databases at the time
of the study. Although it is acknowledged overall individual faecal vir-
omes are dissimilar, analyses of combined virome20,27 and total faecal
metagenome data suggest the existence of a nontrivial common reser-
voir of phages shared among individuals in different geographical
regions.8
Because of the small size of virus genomes compared with
prokaryote genomes, it is relatively easy to achieve greater sequenc-
ing depth than total metagenome studies. Deep sequencing of faecal
viromes (48 Gb of virome DNA across 12 individuals at three differ-
ent time points over a 2-month period; ~1.3 Gb of sequence per vir-
ome) allowed empirical assessment of hypervariation driven by a
unique reverse-transcriptase (RT)-based mechanism in faecal vir-
omes.31 Between 573 and 3390 contigs longer than 1 kb were
assembled from the donors’ viromes. The majority of predicted
genes (72%) within these contigs encoded unknown proteins, but as
with previous studies the majority of sequences were associated
with DNA phages. Only one donor harboured a eukaryotic DNA
virus—Human papilloma virus type 6b. This is typical of faecal vir-
omes of healthy humans, in which recovery of DNA eukaryotic
viruses is rare.19,20,27,32,33 “Diversity-generating retroelements”
(DGRs), RT-based systems that introduce mutations at adenines in
specific repeated sequences,33 were identified in the viromes of 11/
12 subjects studied. Six predicted hypervariable genes encoded
Ig-superfamily b-sandwich domains that have been associated with
viral evasion of the immune system31 and binding of phages to host
mucin glycoproteins.34 Phage enrichment within the mucosa is
thought to protect the host from bacterial infections by limiting the
presence of mucosal bacteria (“bacteriophage adherence to mucus”
model of protection), providing nonhost-derived immunity operating
throughout the GI tract.34
8 | EVOLUTION OF THE INTESTINAL
VIROME, AND THE INFLUENCE OF
ANTIBIOTICS
In-depth analysis of one healthy adult’s faecal virome over 2.5 years
(56 Gb of DNA sequenced over 24 samples taken at 16 time points)
demonstrated its rapid evolution.33 The majority (80%) of 478
assembled contigs persisted over the duration of the study, and
accumulated sequence variation over time. The stability of phage
nucleotide sequences was family-dependent. Temperate phages had
the lowest substitution rate, whereas Microviridae had high substitu-
tion rates (>105 per nt per day), with identification of new viral
species over the study period; numerous new viral species may
emerge in the human gut over the course of a lifetime. Evolution of
DGRs and CRISPRs in phage contigs was also observed. Therefore,
multiple mechanisms contribute to phage sequence variation within
the human faecal virome. Antibiotic therapy influences viromes, not
by affecting VLPs directly but by affecting their prokaryote hosts.35
For example, quinolones have been shown to induce Shiga-
toxin-encoding prophages by Escherichia coli in mice, leading to toxin
production and death of animals.36 In a longitudinal study involving
four individuals on various broad-spectrum, long-term intravenous
antibiotic therapies for Staphylococcus infections, oral viromes were
affected more than faecal viromes by antibiotic treatment, with an
increase in representation of papillomaviruses in the oral virome of
antibiotic-treated patients.35 A nonsignificant increase in antibiotic-
resistance genes was seen in the faecal viromes of the patients. It
was suggested sampling of individuals should be done at more regu-
lar intervals to get a true picture of the effect of antibiotics on vir-
omes. It should also be noted the study was hampered by
confounders relating to age of patients compared with controls and
the patients being on different treatment regimes.
Willner et al37 first suggested the sharing of VLPs among individ-
uals in their study of sputum samples from individuals with lung dis-
ease (Table S1). Later work on oral and faecal viromes of 20
individuals over a 6-month period confirmed this, demonstrating
phages were persistent in these viromes and readily shared among
related and unrelated members of the same household.38 Sharing of
phages encoding virulence or antibiotic-resistance genes has implica-
tions for shaping of microbiomes of those in close contact with one
another, and warrants further study. With respect to antibiotic-resis-
tance genes, their presence may have been over-estimated in human
viromes11,20,27,31,35,37 as these entities are thought to be rarely
encoded in phages.39 Consequently, care should be taken when ana-
lysing data: proper in silico checks with conservative cut-offs are
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required to refine functional assignments and avoid over-interpreta-
tion of data.39 Induction of prophages encoded in prokaryote gen-
omes during antibiotic treatment appears to be more relevant to gut
microbial ecology—with an increased level of generalised transduc-
tion and low level of transfer of antibiotic-resistance genes.39
9 | SSDNA VIRUSES IN THE INTESTINAL
VIROME
To date, only one study has specifically examined the contribution
of ssDNA viruses to the human faecal virome.11 Microviridae were
found to represent the majority (27%-49%) of known phage
sequences in samples from five healthy South Koreans. This overes-
timation of Microviridae abundance was due to preferential amplifica-
tion of small circular genomes by the phi29 polymerase used to
amplify the ssDNA. Corrected abundances suggested the Microviri-
dae represent 3%-9% of known viruses in human faeces. Sequence
analyses of a major capsid protein of the Microviridae and gut bacte-
ria predicted Prevotella and Bacteroides to be the hosts of a number
of these viruses, sharing high sequence similarity with prophage-like
sequences encoded by these bacteria. Newer protocols for amplifica-
tion and sequencing of ssDNA from environmental samples will
improve characterisation of this group of viruses within the human
gut.40-42
10 | RNA PHAGES IN FAECES OF HEALTHY
ADULTS
The GI tract of mammals is one of the natural habitats of RNA
phages, with special relationships appearing to exist between specific
RNA phage groups and their hosts.43 Coliphage RNA viral assem-
blages in the faeces of cows, foxes, elephants, pigs, horses, birds and
humans and found group II and III RNA phages were predominant in
human faeces, while group I and II RNA phages were predominant in
the faeces of other animals. Of the 597 human faecal samples exam-
ined, 76.5% had fewer than 10 pfu/mL sample and 14.6% had
between 10 and 100 pfu/mL sample (20%, w/v, faecal homoge-
nates).
Metagenomics was used to examine RNA viral assemblages in
faecal samples obtained from two healthy adults: two samples were
collected from one donor 6 months apart, with one sample obtained
from the other donor.44 Three shotgun viral cDNA libraries were
generated, with a total of 36,769 viral sequences obtained; 91.5% of
these had significant similarity to sequences in the GenBank data-
base, with three-quarters being most similar to viruses. Most
(25,040/25,779 known) sequences were similar to plant-pathogenic
RNA viruses. Forty-two viral species (2 animal, 35 plant, 1 yeast and
4 phage) were identified in the faecal RNA viral libraries, with Pepper
mild mottle virus (PMMV), a well-characterised plant-pathogenic virus
that infects all species of the genus Capsicum, being the most abun-
dant. Using RT-PCR, PMMV was detected in food and faecal (106-
109 virions/g dry weight faeces) samples from three different indi-
viduals. Prevalence of PMMV in the human population was also
demonstrated, being detected in faecal samples from North Ameri-
can and Singaporean (both 6/9 positive) individuals. In addition to
PMMV, 24 of the 35 plant-pathogenic viruses were associated with
consumable products such as cereals, fruits, tobacco and vegetables,
suggesting a large proportion of faecal RNA viruses come from
exogenous sources. Support for this hypothesis came from the
detection of PMMV in some processed pepper-containing foods.
The amount of virus detected in faeces exceeded that detected in
the ingested foodstuffs, suggesting plant RNA viruses replicate in
the human GI tract; however, no data were presented to support
this hypothesis. Faeces-derived PMMV could infect wax pepper
plants, suggesting humans and other animals could act as transmis-
sion vectors for plant viruses through their digestive tracts. A second
study45 confirmed the presence of PMMV, and other plant RNA
viruses, in human faeces. Studies into the ability of plant viruses to
replicate in the human gut (in epithelial and microbial cells) should
be initiated.44,45
The low numbers of phage sequences retrieved (corresponding
to Haemophilus influenza phage HP2, Roseophage SIO1, phage L cro
and Shigella flexneri phage V44 and enterobacteria phage phiK and
phage phiV1045) reflected earlier findings43 in relation to the low
numbers of RNA phages recovered from human faeces.
11 | ESTABLISHMENT OF THE FAECAL
VIROME
Microscopic examination of the meconium (ie, first faecal sample) of
a newborn infant did not detect any VLPs.32 By the end of the first
week of life, ~108 VLPs/g wet weight faeces could be detected, with
this number seen as an underestimation of the true number due to
high background fluorescence and clumping of the sample. A viral
metagenome was generated from the faeces of the 1-week-old
infant. Similar to adult DNA viral metagenomes, siphophage and
prophage sequences predominated. Eight viral genotypes were pre-
dicted to be present in the infant’s faecal virome, with the most
abundant viral genotype contributing 43.6% to the total. The low
diversity of the infant faecal virome correlated well with the known
low diversity of the faecal bacterial assemblage in the first week of
life. Sequences with significant similarity to podophages and myo-
phages were also detected. More than 50% of the significant hits
were to phages that infect Gram-positive bacteria (Lactobacillus,
Enterococcus, Bacillus, Lactococcus, Streptococcus and Staphylococcus),
with hits to phages that infect Gram-negative bacteria (Bacteroides
and Listonella) also identified. Microarray analyses of viromes
obtained from faecal samples at weeks 1 and 2 of life with probes
constructed from the week 1 sequencing library showed the tempo-
ral nature of the infant gut virome, with >50% sequences that were
at high abundance at week 1 absent at week 2, and the most abun-
dant sequences at week 2 being of medium abundance at week 1.
No sequences were present at high levels at week 1 or 2,
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demonstrating turnover of the most abundant viral sequences over a
short period of time.
Primers designed based on the sequences of the three largest
contigs generated from sequencing library amplified sequences cor-
responding to a Streptococcus pyogenes phage terminase (large sub-
unit), a Bacteroides thetaiotaomicron integrase and Bacillus
thuringiensis phage MZTP02. A portion of the sequence amplified by
the B. thetaiotaomicron integrase primer set was identical to a viral
sequence retrieved in the first adult faecal virome study.32 VLP DNA
was isolated from the breast and formula milk fed to the infant, fae-
cal samples obtained at 1, 2, 5 and 14 weeks of age, and from the
faeces (two samples taken a year apart) of an unrelated adult. All
three VLP sequences were present in the first 3 months of the
infant’s life and did not originate from breast or formula milk. The B.
thetaiotaomicron integrase was detected in all faecal (infant and
adult) samples examined, while the other two VLP sequences were
detected only in the infant faecal samples. It is possible the assay
used in this study was not sensitive enough to detect VLP
sequences in milk samples, as one would assume that populations
would be in very low numbers in these substrates. This point seems
especially relevant given >25% of the sequences identified in the
faecal viral assemblage were most similar to those of phages infect-
ing lactic acid bacteria known to be abundant in breast milk. It is not
known from where the initial infant gut virome originates, although
it has been suggested dietary, environmental and maternal sources
may be sources of inocula.32 In addition, primary infant faecal viruses
may originate from induction of prophages from primary bacterial
colonisers.32
A more-extensive metagenomic study examining the infant (DNA
and RNA) virome in four pairs of twins over the first 24 months of
life (sampling at 0, 3, 6, 9, 12, 18 and 24 months) identified eukary-
otic DNA viruses from month 3 onwards (ssDNA—anelloviruses,
ciroviruses, geminiviruses, nanoviruses, parvoviruses; dsDNA—
adenoviruses, polyomaviruses), but only anelloviruses, circoviruses
and geminiviruses were detected in at least one twin of each pair
between months 3 and 24 of the study.46 Anelloviruses, associated
with host immune status, were most prevalent from 3 months of
age and highly divergent from known anelloviruses, with their abun-
dance peaking at 6-12 months of age. The same anelloviruses were
detected in faecal samples of the same infant collected 12 months
apart, suggesting a persistent or stable source of recurring infec-
tion.46 It was speculated the increase in anelloviruses between 6 and
12 months was the result of lowered immune status associated with
the decrease in maternal IgG, though no data were provided to sup-
port this. Eukaryotic viral (DNA) richness was low at 3 months but
increased thereafter, indicating environmental exposure contributes
to the establishment of this component of the virome. Eukaryotic
RNA viruses (ssRNA—alphaflexiviruses, astrovirsues, caliciviruses,
picornoviruses, tombamoviruses, virgaviruses; dsRNA—chrysoviruses,
picobirnaviruses) were detected less frequently across the study per-
iod, but related twins harboured the same strains of parechovirus
and enterovirus. Phages were detected at high abundance in all
infants across the study period, with the majority of reads belonging
to the order Caudovirales (Siphoviridae > Myoviridae > Podoviridae),
Inoviridae (ssDNA), Microviridae (ssDNA), Corticoviridae and Tectiviri-
dae. No RNA phages were detected in any of the faecal samples.
Phage richness and diversity were greatest at month 0 and
decreased as the infants aged, and the relative abundance of Cau-
dovirales (high at 0 months, low at 24 months) was inversely corre-
lated with the abundance of Microviridae. crAssphage22 was detected
in one sample of one infant, suggesting this phage is not acquired
early in life. Of note, reads associated with the family Lipothrixviridae,
an archaeal virus family, were detected in the faecal virome of all
twins at various points across the study period. Each infant had a
unique faecal virome, though the viromes of related infants were
more similar to one another than nonrelated infants after controlling
for age. Bacterial species richness and diversity increased with age,
being predominated by Firmicutes, Bacteroidetes, Actinobacteria, Ver-
rucomicrobia, Proteobacteria and Fusobacteria at 24 months. An
inverse correlation of phage and bacterial richness (high phage–low
bacteria to low phage–high bacteria) was seen from month 0 to
24 months. The infant faecal virome is suggested, therefore, to dis-
play a reversed predator-prey cycle: ie, limited prey diversity controls
predator abundance.46 The initially high phage population is unsus-
tainable because of low numbers of bacteria colonising the GI tract.
Consequently, the phage assemblage shrinks in size and diversity,
relieving pressure on the bacterial community and allowing it to
establish and colonise the gut.
12 | INFLUENCE OF ENVIRONMENTAL
FACTORS ON DEVELOPMENT OF THE
INFANT VIROME
Differences in birth mode (Caesarean vs vaginal delivery) and diet
(breast- vs formula-feeding; age at which weaning began) were con-
founders in the study of Lim et al.46 Differences in the faecal micro-
biota of breast- and formula-fed infants are well documented, as are
the effects of weaning.47 It is also known that 16S rRNA gene-
based sequencing studies do not always give accurate representa-
tion of Bifidobacterium populations in the infant faecal micro-
biota.48,49 Therefore, shotgun metagenome studies examining the
infant microbiome and virome are required in carefully controlled
populations to study the acquisition and development of the infant
GI virome.
The influence of malnutrition on development of the infant fae-
cal virome was investigated during the first 30 months of life in
eight pairs of healthy twins and 12 pairs of twins discordant for sev-
ere acute malnutrition (six pairs with one twin healthy, one with
marasmus; six pairs with one twin healthy, one with kwashiorkor).50
As with the study of Lim et al46 Anelloviridae were prevalent in early
life, but diminished at 15-18 months of age. In addition, Microviridae
increased in abundance with age. Siphoviridae were the most abun-
dant VLPs during 0-10 months, but then slowly decreased. This
demonstrated that, as with the prokaryotic component of the faecal
microbiota, age affects virome composition in early life. Discordant
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twins could be distinguished from healthy twins based on phage
populations and the presence of higher levels of eukaryotic viruses
of the families Anelloviridae and Circoviridae.
13 | THE INTESTINAL VIROME, IMMUNE
RESPONSE, AND DISEASE
Alterations in the intestinal virome characterised by reduced diver-
sity and altered intestinal barrier function have been associated with
infectious and autoimmune diseases in addition to metabolic disor-
ders and cardiovascular disease (Figure 1). A potential pathogenic
mechanism involves translocation of viruses present in the gut
microbiota across the intestinal epithelial barrier, particularly in situa-
tions of altered and increased permeability that exert immunomodu-
latory effects on the host.51
HIV-1 and rotavirus are known to escape the gut and dissemi-
nate to peripheral tissues via components of the immune sys-
tem.51 Enterocytes are able to recognise specific phage peptides
and transport them across the mucosal barrier.51 HIV patients are
affected by translocation, and have associated systemic inflamma-
tion.52 Changes to the faecal virome and bacterial microbiome
have been seen in HIV patients, with increased numbers of aden-
ovirus-associated sequences and increased bacterial diversity and
richness associated with peripheral CD4 T-cell counts of <200;
phage populations are not detectably affected by HIV disease sta-
tus or anti-retroviral therapies,52 but plasma samples from HIV
patients contain gut microbiota-derived nucleic acids.53 Phages
have been detected in blood samples of healthy humans, while
mycobacteriophages have been found in the blood of patients
with sarcoidosis, and Crohn’s disease (CD), and in healthy individu-
als.51,54 Circulating phages have also been detected in blood sam-
ples after oral administration of antibiotics to patients with
bacterial infections, whereas no phages could be detected in their
blood prior to antibiotic therapy.51 It is not known if these phages
were of GI origin. The presence of phages in the peripheral blood
has been termed “phagemia”.51 However, whether the blood con-
tains its own “baseline” VLP population to which the GI virome
can contribute in disease is unknown.
Human-associated viruses and intact phages and/or their
nucleic acids are immunogenic. Newborns and children vaccinated
with phage (/X147) formed antibodies against the phage within
1 week of exposure.55 Tumour-specific phages can be used to
treat disease by initiating infiltration of neutrophilic granulocytes
in a toll-like-receptor (TLR)-dependent manner.56 Mono-association
of germ-free mice with Murine norovirus (positive strand RNA
virus) was sufficient to replicate the beneficial effects of commen-
sal bacteria, restoring small-intestinal morphology and lymphocyte
function without overt inflammation or disease.57 Presence of
innate lymphoid cells was reduced in the virus-treated mice com-
pared with controls. Inoculation of antibiotic-treated, wild-type
mice with Murine norovirus for 10 days increased villi width,
Paneth cell granules, intestinal T cells and IFN-c expression,
producing comparable but nonidentical results to when antibiotic-
treated mice were inoculated with strains of commensal bacteria.
Intestinal gene expression was affected by Murine norovirus inocu-
lation, influencing lymphoid cell development and immune
responses mostly related to the anti-viral type I interferon (IFN-I)
response; IFN-I signalling was necessary for virus-mediated
improvements in the Murine norovirus-infected mice. Genes associ-
ated with development and function of haematopoietic cells were
also affected. Inoculation of antibiotic-treated mice with Murine
norovirus protected the mice from Citrobacter rodentium super-
infection. The protective effects of the virome may explain recent
findings with respect to treatment of patients with Clostridium diffi-
cile infections with sterile faecal filtrates: based on the published
protocol, the faecal filtrates used in the study are likely to have
contained phages in addition to the “bacterial debris, proteins,
antimicrobial compounds, metabolic products, and oligonucleotides/
DNA” reported.58 Support for a role for phages in the success of
faecal microbial transplants (FMTs) to treat C. difficile infections
comes from a pilot study by Zuo et al59: when donors had higher
diversity (richness) of Caudovirales than recipients, FMT was suc-
cessful; in instances where recipient virome richness was greater
than that of the donor, over half of the recipients experienced dis-
ease recurrence after FMT. Large cohort studies that characterise
donor and recipient viromes are required to validate these
findings.59
14 | THE INTESTINAL VIROME AND
INFLAMMATORY BOWEL DISEASE
The most compelling and direct evidence for enteric viruses playing
a causal role in chronic GI inflammation, however, comes from
studies in mice.60 Mice with a mutation in the autophagy gene
Atg16L1, which in humans predisposes to CD, develop normally
and are symptom-free. However, enteric infection by norovirus
resulted in the manifestation of the disease, although solely having
the virus or the susceptible allele alone did not produce the dis-
ease, demonstrating the importance of virus-susceptibility gene
interactions in disease progression. Using a dextran sulphate sodium
(DSS)-induced rodent model of colitis, importance of the gut virome
to GI immune homeostasis was demonstrated.61 In mice adminis-
tered a cocktail of anti-viral drugs followed by DSS, the animals
treated with anti-virals had much more severe colitis than the ani-
mals with an intact virome, along with greater weight loss and
reduction in colon length. Protective effects of the virome were
mediated by stimulation of both TLR3 and TLR7, but not individu-
ally. Administration of inactivated rotavirus partially restored the
virome-associated protective effect to the anti-viral-treated mice.
TLR3/TLR7-deficient mice were more sensitive to colitis than their
wild-type counterparts. A link to human inflammatory bowel dis-
ease (IBD) is the observation that patients carrying mutations in
both TLR3 and TLR7 had higher rates of hospitalisation compared
with IBD patients without mutations.61
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15 | THE INTESTINAL VIROME IN HUMAN
IBD
A link between the gut virome and CD was first suggested when it
was found CD patients (n = 19) had significantly more VLPs (phages)
in colonic biopsies than healthy individuals (n = 10) (2.9 9 109 vs
1.2 9 108 VLPs/biopsy), and for the CD patients ulcerated mucosa
had significantly fewer VLPs than nonulcerated mucosa (2.1 9 109
vs 4.1 9 109 VLPs/biopsy).9 More recent, small-scale studies have
been undertaken to characterise the gut virome of IBD.29,62-64 A
pilot metagenomic study of ileal and colonic contents of six CD
patients and ileal samples from six non-IBD controls showed CD
DNA-based viromes had higher phage abundance than control sam-
ples.62 However, the ways in which virome data from healthy con-
trols (n = 8) and patients with ileocolic CD (n = 11) were analysed
were found to contribute to interpretation of results.63 Prophages
represented the most hits in the CD samples when unassembled
reads were compared, but were higher in the control group when
the assembled data were compared. Analysis based on assembled
data showed fewer differences between the CD and control group.
Nonrarefied data were used to generate estimators of species rich-
ness: the viromes of CD patients were less diverse than the healthy
patients, but showed greater heterogeneity across samples. The CD
and control samples could not be fully separated into two groups
based on VLP composition and abundance.
A later DNA-based study showed differences in CD patients
related to disease status (newly diagnosed, active onset, active pre-
surgery) and therapy.65 Similar to their previous study, individual
variability and sample origin had a greater effect on the virome than
CD, although more over-represented viruses were found in the CD
viromes than the healthy, and newly diagnosed patients had higher
diversity in faecal and biopsy viromes than those with active disease.
Patients on steroids and/or immunosuppressors had lower diversity
than untreated patients, while those on immunosuppressors only
had lower diversity than those on combination therapy or steroids
only. The study benefitted from recruiting CD and ulcerative colitis
(UC) patients and their family members in the UK (Cambridge) and
USA (Los Angeles), thereby controlling for household factors that
may influence the microbiome.29 An increase in phage-associated
richness (predominantly Caudovirales and Microviridae) was seen in
IBD faecal viromes compared with those of controls. Initial findings
were confirmed using two independent and geographically distinct
US (Boston, Chicago) patient cohorts with matched controls.29 It
was suggested decreases in bacterial richness concomitant with
increases in phage richness may be due to predator-prey dynamics,
but it was unclear how these contribute to the pathogenesis of IBD.
Also proposed was the virome as a target for therapeutic modula-
tion.29 Although sharing some VLPs, CD and UC viromes could be
separated from one another and harboured unique phages. Phages
of Lactococcus, Lactobacillus, Clostridium, Enterococcus and Streptococ-
cus were significantly associated with disease. Similar to other stud-
ies,27,38 there was also conservation of VLPs among members of the
same household. Manrique et al28 found the HGP was perturbed in
the UC (n = 66) and CD (n = 36) viromes of Norman et al29: healthy
subjects harboured on average 62% of the 23 core phages, while
this number was significantly reduced (37% and 30%, respectively) in
UC and CD patients.
Examination of RNA viruses present in colonic tissue from 10 IBD
(6 CD, 4 UC) and five healthy individuals demonstrated IBD patients
carried more mammalian viruses and human pathogens than healthy
individuals; Adenoviridiae were present in the IBD samples but absent
from the healthy controls.64 HERV (human endogenous retroviruses)
were found in the IBD viromes; expression of HERV proteins has been
linked with inflammatory conditions. HERV was present at significantly
higher levels in IBD patients co-infected with herpesviruses. The sig-
nificance of this association with respect to IBD is unknown, but infec-
tion with other viruses may trigger expression of HERV.64
16 | CHALLENGES FACING STUDIES OF
THE HUMAN INTESTINAL VIROME
Metagenomic studies of the virome are not without their limitations
or challenges. Many of these are related to isolation and processing
methods. The majority of studies published to date rely on the use
of 0.2 lm filters, but it is known these halve the number of viruses
detected compared with use of 0.45 lm filters and will not detect
giant viruses.10,66 Consequently, we do not have a true picture of
the diversity of the human virome.
16.1 | Sequencing depth
Characterisation of total faecal metagenomes has, to date, relied
upon generating ~5 Gb of sequence data per sample to allow full
characterisation of microbiomes.15-18 With the exception of a recent
study that generated 5-8 Gb sequence data per sample,59 the most
extensive surveys of virome diversity have sequenced only a fifth of
this depth per sample, with many relying on much lower sequencing
depths for characterisation of viromes. With the exception of the
four viromes generated by Manrique et al28 all viromes generated to
date have relied upon PCR amplification or multiple displacement
amplification (MDA) to generate sufficient DNA for sequencing.
These methods introduce bias into sequencing libraries. For example,
when using the WTA2 kit it is recommended to use the Nextera XT
library preparation kit to avoid cluster-calling problems during Illu-
mina sequencing. However, the Nextera kit causes under-representa-
tion of ends of viral genomes because of the way this kit works.66
CsCl centrifugation has been shown to be the most efficient method
for removing host DNA, but it discriminates against some phages
and is not reproducible; consequently, this method is not suitable for
quantitative studies.67
16.2 | Phage isolation
Methods of recovery of faecal phages have improved recently
(Table 2), so it should be feasible to generate PCR- or MDA-free,
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deep-sequenced viromes to allow greater characterisation of the
human gut virome. The question will then become how many
sequence data are required to adequately characterise the virome.
Current sequencing depths and paucity of available virus genome
sequences (Figure 2) may mean phages that infect different bacterial
hosts may be indistinguishable.20 Low sequencing depth also means
low coverage of VLP genomes within samples, making it difficult to
differentiate between spurious alignments and real virus sequences
and potentially leading to overestimation of VLPs in samples when
relying on automated read alignments.68 Bioinformatics tools are
required that allow differentiation of authentic sequences from
artefacts.
16.3 | Isolation-kit contaminants
Few studies of the human virome have considered the effects of
contaminants in reagents and nucleic acid extraction kits on viral
metagenomes (Table S1), though these are being increasingly recog-
nised in prokaryote-focused studies.26,69,70 Nucleases, proteases and
polymerases used in studies are produced in protein expression sys-
tems, and sequences associated with these expression vectors have
been detected in virome studies.70 Columns used to purify DNA
may introduce parvovirus-like, circoviruses/densoviruses and iri-
doviruses sequences into samples, and it has been suggested their
use should be avoided in virome studies.26,70 Efforts should be made
to prevent cross-contamination of samples when processing samples
for nucleic acid extraction and sequencing.26,70 Low-biomass samples
obtained from non-GI sites will be reliant on PCR-based approaches
for the foreseeable future, and these are most likely to be affected
by contaminants in reagents. Therefore, appropriate negative con-
trols should be included in sequencing studies, to allow the identifi-
cation of sample-associated sequences rather than those from
contaminants.
16.4 | Combining virus isolation and metagenomics
Those studies targeting only the VLPs of the microbiota will not
capture prophage diversity within samples, and will contain little
information to allow studies of phage-host interactions or host
ranges, limiting in-depth analyses of the overall ecology of the gut
microbiome.21 Studying total community metagenomes in conjunc-
tion with VLP-derived metagenomes will provide a more-complete
picture of virus-host interactions in the human gut.21 The greatest
challenge to integrated studies of the whole gut microbiome is
TABLE 3 Available tools for analysis of viruses in total community and viral metagenomes
Name Description Website/reference(s)
PHACCS89 Assesses the biodiversity of viromes; requires knowledge of virus genome
sizes; desktop app
https://sourceforge.net/projects/phaccs/
ACLAME90 Classification of mobile genetic elements; web-based http://aclame.ulb.ac.be
MetaVir 291,92 Annotates viral metagenomes (raw reads or assembled contigs); web-based http://metavir-meb.univ-bpclermont.fr
VIROME93 Classification of predicted open-reading frames (ORFs) from viral
metagenomes; each ORF placed into one of 9 sequence categories;
functional classification; web-based
http://virome.dbi.udel.edu
Vanator94 Perl pipeline using a number of alignment, assembly and analysis tools to
assess metagenomic data derived from Illumina data; virus discovery;
desktop app
https://sourceforge.net/projects/vanator-cvr/
VirSorter95 Detects virus signals in single-cell amplified genomes of uncultivated
organisms or genomic fragments assembled from metagenomic
sequencing; desktop app
https://github.com/simroux/VirSorter
ViromeScan96 Characterises taxonomy of eukaryotic viruses directly from raw reads;
desktop app
https://sourceforge.net/projects/viromescan/
VIP97 Identification of eukaryotic viruses (pathogens, influenza virus) from
metagenomes; desktop app
https://github.com/keylabivdc/VIP
VirusDetect98 Analyses small RNA datasets for known and novel viruses; web-based and
desktop app
http://bioinfo.bti.cornell.edu/tool/VirusDetect/
PHASTER99 PHAge Search Tool—Enhanced Release, rapid identification and annotation
of prophage sequences within bacterial genomes, plasmids and
metagenomic sequences
http://phaster.ca/
VirusSeeker100 BLAST-based sequence analysis pipeline for eukaryotic and prokaryotic
virus discovery and virome composition; desktop app
https://wupathlabs.wustl.edu/virusseeker/
VirHostMatcher74 Computes Oligonucleotide Frequency (ONF) scores between viral and host
sequences in total community metagenomes, and visualises results; higher
predictive accuracy at class and phylum levels
https://github.com/jessieren/VirHostMatcher
VirFinder73 k-mer frequency-based, machine-learning method for virus contig
identification in total community metagenomes
https://github.com/jessieren/VirFinder
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the lack of available phage sequences from isolated viruses (Fig-
ure 2). Because most nucleotide sequences obtained from viral
metagenomes are novel, BLASTN analyses are generally uninfor-
mative.71 It has been stated that isolating “just a few phage gen-
omes from novel environments will greatly increase our
understanding of viral diversity in these environments”.72 Recently,
OligoNucleotide Frequency profiling, in conjunction with abun-
dance profiling and homology methods, has been proposed as a
means of improving identification of microbial hosts for novel
viruses from total community metagenomes73,74; deriving full ben-
efit from this approach relies on classical isolation and genomic
characterisation of viruses and their hosts from environmental
samples. Therefore, it is of utmost importance that isolation of
phages from the GI tract and their genomic characterisation are at
the forefront of future research: incorporation of ecological stud-
ies into those exploiting lytic phages or phage-encoded gene
products for biotechnological or medical applications would be of
great benefit to the research community.
16.5 | Environmental confounders
As with the prokaryote component of the microbiome, the genetic
makeup of an individual’s virome is influenced by diet, nutrition
status, health, socioeconomic group, geographical location, age, life-
style, season and medication.7,20,29,50,75 Immune status, and viral
and human genetics will also affect interactions of the virome with
the host.29,52,75 Virome studies have so far focused mainly on small
human cohorts from restricted geographical locations, and to a
large extent have focussed on characterising phage populations. As
of July 2017, there are ~2040 complete genome sequences avail-
able for the Caudovirales, the main order of phages (Figure 2). Our
coverage of eukaryote-associated infectious viruses is equally poor,
mostly because we do not (1) know how to propagate known
infectious agents and (2) there are a number of medical conditions
speculated to be linked with viral infections (eg, type I diabetes,
chronic fatigue syndrome, obesity) but for which no infectious
agent has been found. It has been estimated over half of human-
infecting viruses remain to be discovered.76 Numerous conditions
in which patients suffer unexplained symptoms may also be virus-
associated. Therefore, there is a need to sample a wide range of
body fluids and tissues from individuals globally to better under-
stand the role of viruses in human health and disease.75 Propaga-
tion and characterisation of prokaryote- and eukaryote-infecting
viruses will require huge efforts to fully characterise extant viral
populations, and there is still a wealth of viral diversity (pathogenic
and nonpathogenic) to be discovered within human viromes. Those
in areas with poor sanitation and crowded living conditions, trav-
ellers, children and the immunocompromised are expected to have
higher viral loads, at least in terms of potentially pathogenic
viruses,75 while pre-term infants, breast- and formula-fed infants
and the elderly are likely to have very different viromes compared
with adults based on the general information we have about the
composition of the human gut microbiome throughout life.27,50
Interactions with pets, insects and wild animals will also influence
the composition of the human virome. From a pathogen perspec-
tive, bush-workers, abattoir workers and individuals exposed to
insect bites have been highlighted as likely sources of new human-
infecting viruses.75
With the advent of high-throughput, inexpensive, sensitive
sequencing methods, it has become possible to study the contribution
of dsDNA, ssDNA and RNA VLPs to the human virome. Gene transfer
agents, which appear to represent defective phages, have not been
examined in the context of the human microbiome or virome, but
may also make a contribution to its genetic content.77,78 Similarly,
exosomes—extracellular vesicles of 40-100 nm in diameter consisting
of proteins, lipids, miRNA, mRNA and DNA—derived from cells lining
the GI epithelium are likely to contribute to nucleic acids found in vir-
omes.79,80 Outer-membrane vesicles, the equivalent (in size and com-
position) of eukaryotic exosomes for Gram-negative bacteria, may
also contribute to what we currently call the virome, as these vesicles
have recently been reported to contain DNA as well as RNA.81
16.6 | Virome-specific bioinformatics tools
Whereas 16S rRNA gene sequence data are readily processed and
analysed using packages such as QIIME and Mothur, no such tools
exist for the analyses of sequence data derived from host-associated
viromes.35 Tools exist for functional annotation of viromes and esti-
mating viral diversity (Table 3). No easy-to-use pipeline that takes
raw reads, strips out host DNA, looks for bacterial contaminants
then assigns taxonomy and functionality to prokaryote and eukary-
ote viruses within samples exists, though efforts are being made to
generate such tools. These will need to take into account the pres-
ence of human endogenous retroviruses, which comprise ~8% of the
human genome and still possess the ability to encode retrovirus poly-
merase and envelope protein and can be reactivated by exogenous
retroviruses such as HIV.53
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